On May 26, 2020, the Board of Directors of the Company approved the Playtika Holding Corp. 2020 Incentive Award Plan (the “Plan”).

As of June 30, 2026, a total of 63,743,006 shares of the Company’s common stock had been allocated to awards granted under the Plan and 16,458,412 shares remained available for future grants.

On May 9, 2024, the Company announced that its Board of Directors authorized a stock repurchase program for up to $150 million of the Company’s common stock. Under the repurchase program, repurchases can be made using a variety of methods, which may include open market purchases, privately negotiated transactions or otherwise. The specific timing, price and size of purchases will depend on prevailing stock prices, general economic and market conditions, and other

considerations. The repurchase program does not obligate the Company to acquire any particular amount of common stock, and may be suspended or discontinued at any time at the Company’s discretion. There were no shares of common stock repurchased and retired during the three months ended June 30, 2026. As of June 30, 2026, $129.0 million remains available under the Company’s stock repurchase program.

The following table summarizes the Company’s stock option activity during the six months ended June 30, 2026:


	Stock	Weighted	Weighted
	Options	Average	Average		Intrinsic
	Outstanding	Remaining	Exercise		Value
	(in millions)	Term (in years)	Price		(in millions)
Outstanding at January 1, 2026	1.1	5.7	$	17.16	$	—
Granted	—		$	—
Exercised	—
Forfeited	(0.3)		$	17.42
Expired	—		$	—
Outstanding at June 30, 2026	0.8	5.3	$	17.09	$	—
Exercisable at June 30, 2026	0.8	5.2	$	17.35	$	—

The Company used the Black-Scholes option pricing model to estimate the grant-date fair value associated with all employee stock options. There were no options granted in the six months ended June 30, 2026 or 2025.

The following table summarizes the Company’s RSU activity during the six months ended June 30, 2026:


		Weighted		Total Fair
		Average		Value of
	Shares	Grant Date		Shares Vested
	(in millions)	Fair Value		(in millions)
Outstanding at January 1, 2026	18.4	$	5.94
Granted	1.6	$	3.46
Vested	(2.8)	$	7.33	$	8.8
Forfeited	(1.6)	$	6.77
Outstanding at June 30, 2026	15.6	$	5.35

The Company used the associated per-share value at the time of grant to determine the compensation cost to be recognized for the RSUs granted during the six months ended June 30, 2026. For grants of RSUs during period when the Company expects to pay dividends, the Company estimates the fair value for compensation cost using the value of its common stock on

the date of grant, reduced by the present value of dividends expected to be paid on its shares of common stock prior to vesting.

The table below summarizes the assumptions used for the RSUs granted during the six months ended June 30, 2025:


									Six months ended June 30,
									2025
Risk-free interest rate									3.70% - 4.22%
Expected dividend yield									5.42% - 7.37%
Expected term in years									2.8 - 3.1

The following table summarizes the Company’s PSU activity during the six months ended June 30, 2026:


		Weighted		Total Fair
		Average		Value of
	Shares(1)	Grant Date		Shares Vested
	(in millions)	Fair Value		(in millions)
Outstanding at January 1, 2026	10.8	$	5.02
Granted	—	$	—
Vested	(2.1)	$	7.14	$	7.4
Forfeited	(2.7)	$	3.92
Outstanding at June 30, 2026	6.0	$	4.75

(1) The number of PSUs outstanding represent the total number of PSUs granted to each recipient eligible to vest if the Company meets its highest specified performance goals for the applicable period.

The following table summarizes stock-based compensation costs as reported by award type (in millions):


	Three months ended June 30,				Six months ended June 30,
	2026		2025		2026		2025
Stock options	$	—	$	0.3	$	0.1	$	0.6
RSUs	9.5		14.0		20.8		29.0
PSUs	3.2		3.4		6.0		13.9
Total stock-based compensation costs	$	12.7	$	17.7	$	26.9	$	43.5

The following table summarizes stock-based compensation costs, net of amounts capitalized, as reported on the Company’s consolidated statement of comprehensive income (in millions):


	Three months ended June 30,				Six months ended June 30,
	2026		2025		2026		2025
Research and development expenses	$	1.8	$	4.3	$	4.2	$	8.8
Sales and marketing expenses	0.7		0.7		1.4		1.5
General and administrative expenses	10.1		12.5		21.1		32.7
Total stock-based compensation costs, net of amounts capitalized	$	12.6	$	17.5	$	26.7	$	43.0

The Company capitalized stock-based compensation of $0.1 million and $0.2 million during the three months ended June 30, 2026 and 2025, respectively, and $0.2 million and $0.5 million during the six months ended June 30, 2026 and 2025, respectively.